Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUY922 in Advanced Solid Malignancies and Breast Cancer
NCT00526045Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2007
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of Luminespib in solid tumor, breast cancer, sponsored by Novartis. Started Jul 2007; status: completed.
02
Drugs
Luminespib
03
Conditions
solid tumorbreast cancer
Beyond the preview
Go deeper on NCT00526045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526045.